Clinical Trial Update: Clinical Study Evaluating Targeted Biopsies and Cytological Imprints in Prostate Cancer [NA]

View source ↗

Summary

The clinical trial evaluating targeted biopsies and cytological imprints in prostate cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Oslo University Hospital | Conditions: Prostate Cancer | NA | Status: WITHDRAWN